ATE435222T1 - Aminobenzimidazole und benzimidazole als inhibitoren der replikation von respiratory syncytial virus - Google Patents
Aminobenzimidazole und benzimidazole als inhibitoren der replikation von respiratory syncytial virusInfo
- Publication number
- ATE435222T1 ATE435222T1 AT04804949T AT04804949T ATE435222T1 AT E435222 T1 ATE435222 T1 AT E435222T1 AT 04804949 T AT04804949 T AT 04804949T AT 04804949 T AT04804949 T AT 04804949T AT E435222 T1 ATE435222 T1 AT E435222T1
- Authority
- AT
- Austria
- Prior art keywords
- aminobenzimidazoles
- benzimidazoles
- replication
- inhibitors
- respiratory syncytial
- Prior art date
Links
- 241000725643 Respiratory syncytial virus Species 0.000 title 1
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104797 | 2003-12-18 | ||
| US56683404P | 2004-04-30 | 2004-04-30 | |
| PCT/EP2004/053613 WO2005058869A1 (en) | 2003-12-18 | 2004-12-20 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE435222T1 true ATE435222T1 (de) | 2009-07-15 |
Family
ID=34924148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04804949T ATE435222T1 (de) | 2003-12-18 | 2004-12-20 | Aminobenzimidazole und benzimidazole als inhibitoren der replikation von respiratory syncytial virus |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8044073B2 (de) |
| EP (1) | EP1697343B1 (de) |
| JP (1) | JP4915734B2 (de) |
| CN (1) | CN1918146B (de) |
| AR (1) | AR046971A1 (de) |
| AT (1) | ATE435222T1 (de) |
| AU (1) | AU2004298457B2 (de) |
| BR (1) | BRPI0417811A (de) |
| CA (1) | CA2548657A1 (de) |
| DK (1) | DK1697343T3 (de) |
| ES (1) | ES2328700T3 (de) |
| MY (1) | MY141292A (de) |
| NZ (1) | NZ547796A (de) |
| PL (1) | PL1697343T3 (de) |
| PT (1) | PT1697343E (de) |
| RU (1) | RU2379302C2 (de) |
| TW (1) | TWI356055B (de) |
| WO (1) | WO2005058869A1 (de) |
| ZA (1) | ZA200605893B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
| AU2006260969B2 (en) * | 2005-06-20 | 2011-11-17 | Janssen Sciences Ireland Uc | 1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) -3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| JP5208962B2 (ja) | 2006-12-22 | 2013-06-12 | アベキサ・リミテッド | 二環式ピリミジノンおよびその使用 |
| AU2013221286B2 (en) | 2012-02-17 | 2017-06-15 | Abbvie Inc. | Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (RSV) |
| AU2014308991B2 (en) | 2013-08-21 | 2019-02-14 | Janssen Biopharma, Inc. | Antiviral compounds |
| MA41614A (fr) | 2015-02-25 | 2018-01-02 | Alios Biopharma Inc | Composés antiviraux |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| LT3483164T (lt) | 2017-03-20 | 2020-05-11 | Forma Therapeutics, Inc. | Pirolpirolo kompozicijos kaip piruvato kinazės (pkr) aktyvatoriai |
| BR112020006334A2 (pt) | 2017-09-29 | 2020-09-24 | Enanta Pharmaceuticals, Inc. | combinação de agentes farmacêuticos como inibidores de rsv |
| EP3594205A1 (de) | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-aryl-derivate zur behandlung einer rna-virusinfektion |
| EP3594206A1 (de) | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-chinolin-derivate zur behandlung einer rna-virusinfektion |
| EP3852791B1 (de) | 2018-09-19 | 2024-07-03 | Novo Nordisk Health Care AG | Aktivierung von pyruvatkinase r |
| EP3853206B1 (de) | 2018-09-19 | 2024-04-10 | Novo Nordisk Health Care AG | Behandlung von sichelzellanämie mit einer pyruvatkinase-r-aktivierenden verbindung |
| HRP20251148T1 (hr) | 2019-09-19 | 2025-11-21 | Novo Nordisk Health Care Ag | Pripravci koji aktiviraju piruvat-kinazu r (pkr) |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE31812B1 (en) * | 1967-02-03 | 1973-01-10 | Merck & Co Inc | Benzimidazole derivatives |
| US4179505A (en) * | 1977-03-30 | 1979-12-18 | Janssen Pharmaceutica N.V. | 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives |
| CA1140119A (en) | 1978-04-03 | 1983-01-25 | Joseph Torremans | N-heterocyclyl-4-piperidinamines |
| US4492708A (en) * | 1982-09-27 | 1985-01-08 | Eli Lilly And Company | Antiviral benzimidazoles |
| KR100190299B1 (ko) | 1990-07-19 | 1999-06-01 | 디르크 반테 | 신규한 옥사졸릴 유도체 |
| AU7195694A (en) * | 1993-07-19 | 1995-02-20 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives useful as dopamine receptor antagonist, 5-ht receptor agonist or alpha1 receptor antagonist |
| US5545653A (en) * | 1995-06-07 | 1996-08-13 | Eli Lilly And Company | Anti-viral compounds |
| CA2227688C (en) | 1998-01-16 | 2007-07-31 | James W. Critchfield | Methods and compositions for inhibition of viral replication |
| SI1196408T1 (en) * | 1999-06-28 | 2005-02-28 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
| ES2215670T3 (es) | 1999-06-28 | 2004-10-16 | Janssen Pharmaceutica N.V. | Inhibidores de la replicacion del virus sincitial respiratorio. |
| IL147327A0 (en) * | 1999-06-28 | 2002-08-14 | Janssen Pharmaceutica Nv | Respiratory syncytial virus replication inhibitors |
| US20040157866A1 (en) | 2001-04-30 | 2004-08-12 | Hisashi Takasugi | Amide compounds |
| US7030150B2 (en) * | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
| FR2833948B1 (fr) | 2001-12-21 | 2004-02-06 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et leur utilisation en tant que medicament |
-
2004
- 2004-12-20 TW TW093139737A patent/TWI356055B/zh not_active IP Right Cessation
- 2004-12-20 ES ES04804949T patent/ES2328700T3/es not_active Expired - Lifetime
- 2004-12-20 CN CN2004800416897A patent/CN1918146B/zh not_active Expired - Lifetime
- 2004-12-20 PL PL04804949T patent/PL1697343T3/pl unknown
- 2004-12-20 EP EP04804949A patent/EP1697343B1/de not_active Expired - Lifetime
- 2004-12-20 DK DK04804949T patent/DK1697343T3/da active
- 2004-12-20 CA CA002548657A patent/CA2548657A1/en not_active Abandoned
- 2004-12-20 MY MYPI20045261A patent/MY141292A/en unknown
- 2004-12-20 BR BRPI0417811-4A patent/BRPI0417811A/pt not_active IP Right Cessation
- 2004-12-20 US US10/596,514 patent/US8044073B2/en active Active
- 2004-12-20 RU RU2006125726/04A patent/RU2379302C2/ru not_active IP Right Cessation
- 2004-12-20 JP JP2006544463A patent/JP4915734B2/ja not_active Expired - Fee Related
- 2004-12-20 NZ NZ547796A patent/NZ547796A/en not_active IP Right Cessation
- 2004-12-20 AU AU2004298457A patent/AU2004298457B2/en not_active Ceased
- 2004-12-20 AT AT04804949T patent/ATE435222T1/de active
- 2004-12-20 AR ARP040104806A patent/AR046971A1/es not_active Application Discontinuation
- 2004-12-20 PT PT04804949T patent/PT1697343E/pt unknown
- 2004-12-20 WO PCT/EP2004/053613 patent/WO2005058869A1/en not_active Ceased
-
2006
- 2006-07-17 ZA ZA200605893A patent/ZA200605893B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200605893B (en) | 2007-11-28 |
| RU2379302C2 (ru) | 2010-01-20 |
| US8044073B2 (en) | 2011-10-25 |
| EP1697343B1 (de) | 2009-07-01 |
| JP2007514717A (ja) | 2007-06-07 |
| NZ547796A (en) | 2009-04-30 |
| DK1697343T3 (da) | 2009-10-05 |
| US20070099924A1 (en) | 2007-05-03 |
| AR046971A1 (es) | 2006-01-04 |
| PT1697343E (pt) | 2009-09-16 |
| CN1918146B (zh) | 2011-09-14 |
| TWI356055B (en) | 2012-01-11 |
| MY141292A (en) | 2010-04-16 |
| EP1697343A1 (de) | 2006-09-06 |
| WO2005058869A1 (en) | 2005-06-30 |
| PL1697343T3 (pl) | 2009-12-31 |
| RU2006125726A (ru) | 2008-01-27 |
| BRPI0417811A (pt) | 2007-03-27 |
| AU2004298457A1 (en) | 2005-06-30 |
| CN1918146A (zh) | 2007-02-21 |
| CA2548657A1 (en) | 2005-06-30 |
| AU2004298457B2 (en) | 2010-05-27 |
| TW200602327A (en) | 2006-01-16 |
| ES2328700T3 (es) | 2009-11-17 |
| JP4915734B2 (ja) | 2012-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE388950T1 (de) | Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus | |
| ATE435222T1 (de) | Aminobenzimidazole und benzimidazole als inhibitoren der replikation von respiratory syncytial virus | |
| PL374832A1 (pl) | Nowe podstawione benzoimidazolowe postacie dawkowe i sposoby ich stosowania | |
| ATE471319T1 (de) | Chromansubstituierte benzimidazole und ihre verwendung als säurepumpenhemmer | |
| DE602004031776D1 (de) | Piperidinamino-benzimidazol-derivate al respiratorisches syncytialvirus replikation inhibitoren | |
| ATE343572T1 (de) | Benzimidazole und benzothiazole als inhibitoren der map-kinase | |
| ATE461930T1 (de) | Harnstoffderivate von tropan, ihre herstellung und ihre therapeutische anwendung | |
| DE602004022171D1 (de) | Teilchenförmiges holzschutzmittel und herstellungsverfahren dafür | |
| ATE479684T1 (de) | Azabenzofuransubstituierte thioharnstoffe als inhibitoren der virusreplikation | |
| BRPI0821558A2 (pt) | virus da estomatite vesicular atenuado geneticamente modificado, ecomposições e métodos de uso dessas | |
| DK1924577T3 (da) | Substituerede benzimidazoler og fremgangsmåder til fremstilling | |
| HRP20130399T1 (hr) | Terapeutska upotreba inhibitora farenziltransferaze i postupci praä†enja njihove efikasnosti | |
| EP2140005A4 (de) | Antagonisten von liganden und verwendungen davon | |
| ATE447404T1 (de) | Substituierte benzazole und ihre verwendung als raf-kinase-hemmer | |
| ATE531720T1 (de) | Aza-benzofuranylverbindungen und anwendungsverfahren dafür | |
| SI1482932T1 (sl) | N3-alkilirani derivati benzimidazola kot inhibitorji mek | |
| AT509493A5 (de) | Feste arzneiform von olmesartan medoxomil und amlodipin | |
| BRPI0808025A2 (pt) | Composto de benzimidazol e uso farmacêutico do mesmo | |
| ATE386517T1 (de) | Substituierte benzimidazole und ihre anwendung in der krebsbehandlung | |
| DE602007011398D1 (de) | Trialkylsilylbenzylaminocarboxyindole, indazole und indoline und ihre verwendung zur behandlung von cetp-vermittelten erkrankungen | |
| DE602006018970D1 (de) | Hunde-influenza-virus und relevante zusammensetzungen und anwendungsverfahren | |
| ATE499361T1 (de) | 5- oder 6-substituierte benzimidazolderivate als inhibitoren der replikation des respiratory syncytial virus | |
| DE602006017183D1 (de) | Benzimidazolderivat und anwendung davon | |
| PL377180A1 (pl) | Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz | |
| ATE540039T1 (de) | Neue derivate von (verbrücktes piperazinyl)-1- alcanon und deren verwendung als p75-inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1697343 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1697343 Country of ref document: EP |